Cargando…
Multimodality Therapy Including Proton Beam Therapy for AFP Producing Esophageal Cancer with Multiple Liver Metastases
A 50-year-old man who presented with a fever and epigastralgia was diagnosed to have esophageal carcinoma which was identified as poorly differentiated adenocarcinoma producing alpha-fetoprotein (AFP) with Barrett's esophagus. Computed tomography revealed multiple liver metastases and lymph nod...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148179/ https://www.ncbi.nlm.nih.gov/pubmed/29607947 http://dx.doi.org/10.2169/internalmedicine.0270-17 |
_version_ | 1783356716759384064 |
---|---|
author | Miyazaki, Tatsuya Sohda, Makoto Sakai, Makoto Kumakura, Yuji Yoshida, Tomonori Kuriyama, Kengo Yokobori, Takehiko Miyazaki, Masaya Hirato, Junko Okumura, Toshiyuki Ishikawa, Hitoshi Sakurai, Hideyuki Kuwano, Hiroyuki |
author_facet | Miyazaki, Tatsuya Sohda, Makoto Sakai, Makoto Kumakura, Yuji Yoshida, Tomonori Kuriyama, Kengo Yokobori, Takehiko Miyazaki, Masaya Hirato, Junko Okumura, Toshiyuki Ishikawa, Hitoshi Sakurai, Hideyuki Kuwano, Hiroyuki |
author_sort | Miyazaki, Tatsuya |
collection | PubMed |
description | A 50-year-old man who presented with a fever and epigastralgia was diagnosed to have esophageal carcinoma which was identified as poorly differentiated adenocarcinoma producing alpha-fetoprotein (AFP) with Barrett's esophagus. Computed tomography revealed multiple liver metastases and lymph node metastases surrounding the stomach. We first performed chemotherapy for the systemic lesions and proton beam therapy for the local control of lesions without complete remission and we were able to successfully control the frequently recurring lesions by proton beam therapy, cryotherapy and chemotherapy. A complete response has been maintained for 16 months and the overall survival time is 4 years and 2 months. Proton beam therapy for primary esophageal cancer and metastatic lesions was thus found to be an effective therapeutic option for such cases. |
format | Online Article Text |
id | pubmed-6148179 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Japanese Society of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-61481792018-09-25 Multimodality Therapy Including Proton Beam Therapy for AFP Producing Esophageal Cancer with Multiple Liver Metastases Miyazaki, Tatsuya Sohda, Makoto Sakai, Makoto Kumakura, Yuji Yoshida, Tomonori Kuriyama, Kengo Yokobori, Takehiko Miyazaki, Masaya Hirato, Junko Okumura, Toshiyuki Ishikawa, Hitoshi Sakurai, Hideyuki Kuwano, Hiroyuki Intern Med Case Report A 50-year-old man who presented with a fever and epigastralgia was diagnosed to have esophageal carcinoma which was identified as poorly differentiated adenocarcinoma producing alpha-fetoprotein (AFP) with Barrett's esophagus. Computed tomography revealed multiple liver metastases and lymph node metastases surrounding the stomach. We first performed chemotherapy for the systemic lesions and proton beam therapy for the local control of lesions without complete remission and we were able to successfully control the frequently recurring lesions by proton beam therapy, cryotherapy and chemotherapy. A complete response has been maintained for 16 months and the overall survival time is 4 years and 2 months. Proton beam therapy for primary esophageal cancer and metastatic lesions was thus found to be an effective therapeutic option for such cases. The Japanese Society of Internal Medicine 2018-03-30 2018-08-15 /pmc/articles/PMC6148179/ /pubmed/29607947 http://dx.doi.org/10.2169/internalmedicine.0270-17 Text en Copyright © 2018 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Miyazaki, Tatsuya Sohda, Makoto Sakai, Makoto Kumakura, Yuji Yoshida, Tomonori Kuriyama, Kengo Yokobori, Takehiko Miyazaki, Masaya Hirato, Junko Okumura, Toshiyuki Ishikawa, Hitoshi Sakurai, Hideyuki Kuwano, Hiroyuki Multimodality Therapy Including Proton Beam Therapy for AFP Producing Esophageal Cancer with Multiple Liver Metastases |
title | Multimodality Therapy Including Proton Beam Therapy for AFP Producing Esophageal Cancer with Multiple Liver Metastases |
title_full | Multimodality Therapy Including Proton Beam Therapy for AFP Producing Esophageal Cancer with Multiple Liver Metastases |
title_fullStr | Multimodality Therapy Including Proton Beam Therapy for AFP Producing Esophageal Cancer with Multiple Liver Metastases |
title_full_unstemmed | Multimodality Therapy Including Proton Beam Therapy for AFP Producing Esophageal Cancer with Multiple Liver Metastases |
title_short | Multimodality Therapy Including Proton Beam Therapy for AFP Producing Esophageal Cancer with Multiple Liver Metastases |
title_sort | multimodality therapy including proton beam therapy for afp producing esophageal cancer with multiple liver metastases |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148179/ https://www.ncbi.nlm.nih.gov/pubmed/29607947 http://dx.doi.org/10.2169/internalmedicine.0270-17 |
work_keys_str_mv | AT miyazakitatsuya multimodalitytherapyincludingprotonbeamtherapyforafpproducingesophagealcancerwithmultiplelivermetastases AT sohdamakoto multimodalitytherapyincludingprotonbeamtherapyforafpproducingesophagealcancerwithmultiplelivermetastases AT sakaimakoto multimodalitytherapyincludingprotonbeamtherapyforafpproducingesophagealcancerwithmultiplelivermetastases AT kumakurayuji multimodalitytherapyincludingprotonbeamtherapyforafpproducingesophagealcancerwithmultiplelivermetastases AT yoshidatomonori multimodalitytherapyincludingprotonbeamtherapyforafpproducingesophagealcancerwithmultiplelivermetastases AT kuriyamakengo multimodalitytherapyincludingprotonbeamtherapyforafpproducingesophagealcancerwithmultiplelivermetastases AT yokoboritakehiko multimodalitytherapyincludingprotonbeamtherapyforafpproducingesophagealcancerwithmultiplelivermetastases AT miyazakimasaya multimodalitytherapyincludingprotonbeamtherapyforafpproducingesophagealcancerwithmultiplelivermetastases AT hiratojunko multimodalitytherapyincludingprotonbeamtherapyforafpproducingesophagealcancerwithmultiplelivermetastases AT okumuratoshiyuki multimodalitytherapyincludingprotonbeamtherapyforafpproducingesophagealcancerwithmultiplelivermetastases AT ishikawahitoshi multimodalitytherapyincludingprotonbeamtherapyforafpproducingesophagealcancerwithmultiplelivermetastases AT sakuraihideyuki multimodalitytherapyincludingprotonbeamtherapyforafpproducingesophagealcancerwithmultiplelivermetastases AT kuwanohiroyuki multimodalitytherapyincludingprotonbeamtherapyforafpproducingesophagealcancerwithmultiplelivermetastases |